Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

Are uber-style platforms the future of non-medicalised homecare?

Healthcare Nova chats to Adam Pike, co-founder and CEO of SuperCarers, which brings the sharing economy to non-medicalised homecare in the UK but is looking to expand into China and Australia. Is he doing to homecare what Uber did for personal transportation? Adam Pike founded the platform with his brother in 2015 after their mother’s […]

Outpatient sector in South Africa and Brazil, psychiatry in GCC + hospitals in India

We continue to add to our database of the Top 1,200 private operators in Emerging markets.  We've just looked at outpatient chains in Brazil and South Africa, which are growing fast offering primary care, some specialist outpatient work and a bit of ambulatory surgery. We've also identified two rare psychiatric hospitals in the GCC where there are huge taboos around mental health. The database gives you a clear and accurate overview of the healthcare services sector from Chile to China.   In South Africa we found a thriving outpatient sector.  Intercare (which we interviewed here) has recently sold a stake to Mediclinic. We identified several direct competitors including Advanced Health, which is listed on the JSE.  In Brazil we found a series of fast-growing outpatient clinics targeting rapid roll outs. They include Dr Consulta, GlobalMed and Clinica Fares. The database now has 90 outpatient chains. In the GCC a good contact identified the two reputable players in psychiatry, a taboo area. We plan to add more private psychiatry units. In India we've added a range of operators including regional players in medicalised homecare. 

Finnish nursing home group Hovi expands in Singapore

Family-owned Finnish nursing home group Hovi has made its first venture abroad. It has entered Southeast Asia by setting up an elderly day-care centre in Singapore. Group CEO Jussi Peltonen tells HBI of plans to further expand in the region.

Where is the genetics industry headed?

The company to offer the first thousand dollar genome claims it will soon have a monopoly in genetics to rival that of Amazon in retail. In doing so, could Veritas Genetics finally deliver on the false promises of the industry and revolutionise healthcare as a whole? 

Find Us